本地药品生产能力评估报告.pdf

1、LOCAL MANUFACTURING OF MEDICINES REPORT ON CAPACITY ASSESSMENT SAPICS 2024IntroductionRationale/Problem Statement 1.Mismatch between market demand and supply2.85%of essential meds not manufactured locally 3.Imports account for 70%of the total Kenya Pharma Market Size4.20%of the total health expendit

2、ure for HPT are from imports which accounted to KES 76 bn in 2020Objectives of the Assessment1.To understand the profile and current scope of the local pharmaceutical industries in Kenya2.To assess the extent to which essential medicines are currently manufactured locally3.To gather market intellige

3、nce on current markets served4.To evaluate the prevailing local manufacturing capacities5.To identify challenges faced by local manufacturers6.To identify proposed solutions by the local manufacturers to inform strategies for increasing local production of medicinesThe President pronouncement in Oct

4、ober 2023-At least 50%of health products and technologies in essential lists should be sourced locally by 2026MethodologySampling Sampling frame of 41 local manufacturers was obtained from the PPB.4 manufacturers had closed permanently5 had closed for Corrective and Preventive Action(CAPA)2 companie

5、s had changed their manufacturing scope from human to veterinary medicine30 sites were identified for the assessmentData Collection ProcessAssessment done from 5th February to 16th Feb 2024Team composition:3 to 4 members drawn from DHPT,ARC,KHF and HPA.Team-Leads from DHPTConsent and confidentiality

6、 forms were signed by both parties;A copy was to retained on siteData collection tools:Online tool was filled on Kobocollect app(using tablets)Excel template were filled and submitted to the Team leadsKEY FINDINGSCompany Profiles&Scope Products Range&VolumesCompany Capacity&TechnologyMarkets Served/